What Is Sepsis?

Sepsis is a life-threatening medical condition defined as organ dysfunction caused by a dysregulated host response to infection. It arises when the immune system's reaction to an infectious agent, whether bacterial, viral, fungal, or parasitic, becomes pathologically amplified and begins damaging the body's own tissues and organs rather than being confined to the site of infection. The condition exists on a clinical spectrum: infection without systemic involvement at one end, septic shock with refractory hypotension and markedly elevated mortality at the other.

The current clinical definition, known as Sepsis-3, was established by an international task force in 2016 and replaced earlier frameworks based on the systemic inflammatory response syndrome (SIRS) criteria. The Sepsis-3 definition emphasizes organ dysfunction, assessed using the Sequential Organ Failure Assessment (SOFA) score, as the distinguishing feature separating sepsis from uncomplicated infection. An overview of this framework is provided in the NIH National Institute of General Medical Sciences fact sheet on sepsis, which notes that sepsis affects over 1.7 million adults in the United States annually.

Pathophysiology and Immune Response

The pathophysiology of sepsis involves simultaneous and interacting activation of pro-inflammatory and anti-inflammatory arms of the immune system. Pattern recognition receptors on monocytes, macrophages, and neutrophils detect pathogen-associated molecular patterns and danger-associated molecular patterns, triggering the release of cytokines including tumor necrosis factor-alpha, interleukins 1 and 6, and numerous other mediators. This cytokine cascade leads to systemic endothelial activation, increased vascular permeability, and coagulation abnormalities.

The endothelium is a primary site of injury in sepsis. Microvascular dysfunction impairs oxygen delivery to tissues, and activation of the coagulation cascade can produce disseminated intravascular coagulation (DIC), in which simultaneous clotting and hemorrhage occur in multiple organs. A PMC review on sepsis pathophysiology and therapeutic concepts traces how these interconnected mechanisms lead to the multi-organ dysfunction that characterizes severe sepsis.

Diagnosis and Biomarkers

Clinical diagnosis relies on identifying infection as a probable or confirmed source combined with evidence of organ dysfunction as indicated by an acute change in SOFA score of two points or more. Bedside screening tools such as the quick SOFA (qSOFA) score, which assesses altered mental status, respiratory rate, and systolic blood pressure, aid rapid identification of at-risk patients outside intensive care settings.

Laboratory evaluation includes blood cultures to identify the causative organism, a complete blood count, metabolic panel, and serum lactate measurement. Elevated lactate indicates impaired cellular oxygen utilization and is associated with higher mortality even in the absence of overt hypotension. Procalcitonin and C-reactive protein are the most widely used biomarkers for systemic infection, although neither is sufficiently specific to confirm sepsis independently. The PMC article on sepsis evolution in definition, pathophysiology, and treatment reviews the evidence base for each of these diagnostic tools.

Treatment and Management

Early recognition and prompt intervention are the principal determinants of outcome. The Surviving Sepsis Campaign, an international quality improvement initiative, has developed hour-by-hour bundles specifying the initial management steps. Broad-spectrum intravenous antibiotics should be administered within one hour of suspected sepsis, following blood culture collection; each hour of delay in antibiotic administration is associated with measurable increases in hospital mortality.

Fluid resuscitation with crystalloid solutions addresses the relative hypovolemia produced by vasodilation and capillary leak. When adequate fluid resuscitation fails to restore blood pressure, vasopressors, primarily norepinephrine, are used to maintain mean arterial pressure. Source control, meaning physical removal or drainage of the infectious source, is essential when an anatomical source is present and amenable to intervention.

Applications

Sepsis research and management have applications in a wide range of fields, including:

• Clinical decision support systems for early recognition in emergency and intensive care settings
• Biomedical engineering development of point-of-care diagnostic devices and rapid biomarker assays
• Wearable monitoring platforms for continuous vital sign tracking in high-risk patients
• Machine learning models trained on electronic health record data to predict sepsis onset
• Global health initiatives targeting infection prevention in low-resource clinical environments